In accordance with the Food and Drug Safety Administration's change order for pharmaceutical manufacturing (import) items (Drug Management Division - No. 1923, effective date 2010.03.15), the efficacy/effect, usage/dosage, and precautions for use of Silumin Capsule 16.95mg have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Silumin capsule 16.95mg
Attachments are original documents and may be in Korean. English editions are labeled separately.
Silumin Capsule.hwpSilumin Capsule.hwp · 27 KBDownload ↓